BlackRock Advisors’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

BlackRock Advisors’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-12,121	Closed	-$5K	–	3841
2016 Q2	$5K	Hold	12,121	–	–	﹤0.01%	3682
2016 Q1	$33K	Sell	12,121 -12,364	-50%	-$34.7K	﹤0.01%	3302
2015 Q4	$76K	Buy	24,485 +11,609	+90%	+$52.3K	﹤0.01%	3049
2015 Q3	$57K	Sell	12,876 -66,921	-84%	-$393K	﹤0.01%	3293
2015 Q2	$456K	Sell	79,797 -2,559	-3%	-$17.5K	﹤0.01%	2256
2015 Q1	$737K	Buy	+82,356	New	+$662K	﹤0.01%	1774

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BlackRock Advisors's EPRS Position: Q3 2016 in Review

BlackRock Advisors sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 12,121 shares — an estimated $5K sold.

BlackRock Advisors first reported a position in EPRS in Q1 2015 and held it in 6 quarters. The position peaked at $737K in Q1 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

BlackRock Advisors reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
BlackRock Advisors sold 12,121 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $5K.
BlackRock Advisors first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q1 2015 and held it in 6 quarters.
BlackRock Advisors's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $737K in Q1 2015.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on BlackRock Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.